Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00-Reference-Cited by-同舟云学术

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00

Published:2008-05 Issue:5 Volume:19 Page:853-860
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fountzilas G.,Dafni U.,Gogas H.,Linardou H.,Kalofonos H.P.,Briasoulis E.,Pectasides D.,Samantas E.,Bafaloukos D.,Stathopoulos G.P.,Karina M.,Papadimitriou C.,Skarlos D.,Pisanidis N.,Papakostas P.,Markopoulos C.,Tzorakoeleftherakis E.,Dimitrakakis K.,Makrantonakis P.,Xiros N.,Polichronis A.,Varthalitis I.,Karanikiotis C.,Dimopoulos A.M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/5/853/398768/mdm539.pdf

Reference25 articles.

1. Estimates of the cancer incidence and mortality in Europe in 2006;Ferlay;Ann Oncol,2007

2. The decrease in breast-cancer incidence in 2003 in the United States;Ravdin;N Engl J Med,2007

3. Theoretical concepts and the emerging role of taxanes in adjuvant therapy;Norton;Oncologist,2001

4. Selection of adjuvant chemotherapy for treatment of node-positive breast cancer;Trudeau;Lancet Oncol,2005

5. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results;Bonadonna;JAMA,1995

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study;Cancers;2022-11-16

2. Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial;British Journal of Cancer;2022-05-24

3. Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review;Expert Review of Anticancer Therapy;2021-11-02

4. Nutrition and melanoma prevention;Clinics in Dermatology;2021-10

5. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?;Cancer Immunology, Immunotherapy;2020-04-18